Literature DB >> 16449266

Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis.

J A Smith1, E C Owen, A M Jones, M E Dodd, A K Webb, A Woodcock.   

Abstract

BACKGROUND: Little is known about cough frequency in adults with cystic fibrosis (CF). This study aimed to determine (1) daytime and overnight cough rates in patients with CF at the beginning and end of a course of antibiotics for treatment of an exacerbation; (2) the relationship between cough frequencies and standard clinical measures of disease; and (3) the relationship between objective cough rates and the subjective assessment of cough.
METHODS: Nineteen adult patients admitted with a pulmonary exacerbation performed daytime and overnight sound recordings on admission; 13 had repeat recordings prior to discharge. Coughs were manually quantified in cough seconds (time spent coughing). Patients subjectively scored their cough using a visual analogue scale (VAS) and numerical score. Lung function, C-reactive protein (CRP) levels, and sputum weights were recorded.
RESULTS: Cough rates fell substantially with treatment; median fall in cough rate was 51.3% (IQR 32.3-77.5) (p<0.001) for daytime and 72.2% (28.6-90.1) (p = 0.049) for overnight. Multivariate regression analyses showed that forced expiratory volume in 1 second and CRP levels predicted overnight cough rates on admission. On discharge, sputum volume predicted daytime cough rates. Only the change in overnight VAS correlated with the change in objective cough rates.
CONCLUSIONS: The cough rate significantly decreases with treatment of a pulmonary exacerbation in adults with CF. Lung function, sputum volume, and CRP influences the cough rate, with the effects differing from day to night and between admission and discharge. Subjective reporting of a nocturnal cough may indicate a pulmonary exacerbation of CF in adults.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449266      PMCID: PMC2111194          DOI: 10.1136/thx.2005.050963

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  20 in total

1.  Defining a pulmonary exacerbation in cystic fibrosis.

Authors:  M Rosenfeld; J Emerson; J Williams-Warren; M Pepe; A Smith; A B Montgomery; B Ramsey
Journal:  J Pediatr       Date:  2001-09       Impact factor: 4.406

2.  Objective monitoring of cough in children with cystic fibrosis.

Authors:  Refika Hamutcu; Jackie Francis; Fazilet Karakoc; Andrew Bush
Journal:  Pediatr Pulmonol       Date:  2002-11

3.  Frequency and perception of cough severity.

Authors:  A B Chang; P D Phelan; C F Robertson; R G Newman; S M Sawyer
Journal:  J Paediatr Child Health       Date:  2001-04       Impact factor: 1.954

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Prevalence and mechanisms of gastro-oesophageal reflux in adult cystic fibrosis patients.

Authors:  M J Ledson; J Tran; M J Walshaw
Journal:  J R Soc Med       Date:  1998-01       Impact factor: 5.344

6.  Induced sputum inflammatory mediator concentrations in chronic cough.

Authors:  Surinder S Birring; Debbie Parker; Christopher E Brightling; Peter Bradding; Andrew J Wardlaw; Ian D Pavord
Journal:  Am J Respir Crit Care Med       Date:  2003-09-25       Impact factor: 21.405

7.  Comparison of objective and subjective measurements of cough frequency in patients with seasonal allergic rhinitis.

Authors:  Jason Krahnke; Deborah Gentile; Betty Angelini; Melvin Danzig; David Skoner
Journal:  Ann Allergy Asthma Immunol       Date:  2004-09       Impact factor: 6.347

8.  Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough.

Authors:  Rekha Chaudhuri; Alex D McMahon; Lorna J Thomson; Kirsten J MacLeod; Charles P McSharry; Eric Livingston; Anne McKay; Neil C Thomson
Journal:  J Allergy Clin Immunol       Date:  2004-06       Impact factor: 10.793

9.  Nocturnal cough in patients with chronic bronchitis and emphysema.

Authors:  J T Power; I C Stewart; J J Connaughton; H M Brash; C M Shapiro; D C Flenley; N J Douglas
Journal:  Am Rev Respir Dis       Date:  1984-12

10.  Frequency, consequences and pharmacological treatment of gastroesophageal reflux in children with cystic fibrosis.

Authors:  Jacek Brodzicki; Maria Trawińska-Bartnicka; Maria Korzon
Journal:  Med Sci Monit       Date:  2002-07
View more
  18 in total

Review 1.  New developments in the objective assessment of cough.

Authors:  Jaclyn Smith; Ashley Woodcock
Journal:  Lung       Date:  2007-12-09       Impact factor: 2.584

2.  Self-reported physical and psychological symptom burden in adults with cystic fibrosis.

Authors:  Gregory S Sawicki; Deborah E Sellers; Walter M Robinson
Journal:  J Pain Symptom Manage       Date:  2008-01-22       Impact factor: 3.612

Review 3.  Cystic Fibrosis and the Nervous System.

Authors:  Leah R Reznikov
Journal:  Chest       Date:  2016-11-19       Impact factor: 9.410

4.  The objective assessment of cough frequency: accuracy of the LR102 device.

Authors:  Sophie Leconte; Giuseppe Liistro; Patrick Lebecque; Jean-Marie Degryse
Journal:  Cough       Date:  2011-12-01

5.  Objective cough frequency in Idiopathic Pulmonary Fibrosis.

Authors:  Angela L Key; Kimberley Holt; Andrew Hamilton; Jaclyn A Smith; John E Earis
Journal:  Cough       Date:  2010-06-21

Review 6.  Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.

Authors:  Christopher H Goss; Jane L Burns
Journal:  Thorax       Date:  2007-04       Impact factor: 9.139

7.  Family caregiver perspectives on symptoms and treatments for patients dying from complications of cystic fibrosis.

Authors:  Elisabeth P Dellon; Mitchell D Shores; Katherine I Nelson; Joanne Wolfe; Terry L Noah; Laura C Hanson
Journal:  J Pain Symptom Manage       Date:  2010-09-17       Impact factor: 3.612

8.  Chronic cough: how do cough reflex sensitivity and subjective assessments correlate with objective cough counts during ambulatory monitoring?

Authors:  Samantha Clare Decalmer; Deborah Webster; Angela Alice Kelsall; Kevin McGuinness; Ashley Arthur Woodcock; Jaclyn Ann Smith
Journal:  Thorax       Date:  2006-11-13       Impact factor: 9.139

Review 9.  Cough and its importance in COPD.

Authors:  Jaclyn Smith; Ashley Woodcock
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  Cough in adult cystic fibrosis: diagnosis and response to fundoplication.

Authors:  Hosnieh Fathi; Tanya Moon; Jo Donaldson; Warren Jackson; Peter Sedman; Alyn H Morice
Journal:  Cough       Date:  2009-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.